AIse Bio provides an AI-powered software platform, Alchemist™, that optimizes protein expression for E. coli, yeast, and CHO cells. The service replaces expensive and time-consuming wet-lab experiments with fast, affordable online predictions, accelerating research and reducing costs by up to 90%. It prioritizes data security and client IP ownership.
- Artificial Intelligence
- Biotechnology
- Drug Discovery & Therapeutics
- Healthcare Technology
- Software Only
Funding
Funding not disclosed
Founders
Product
Problem
Traditional protein production optimization relies on expensive and time-consuming wet-lab experiments, often involving months of trial-and-error. This slows down research and strains R&D budgets, creating a bottleneck for projects that depend on efficient protein expression.
Solution
AIse Bio offers the Alchemist™, an AI-enabled software service that replaces physical optimization experiments with fast, affordable online predictions. The platform uses machine learning to analyze protein sequences and predict optimal expression conditions for E. coli, S. cerevisiae, and CHO cells. This approach accelerates projects by delivering AI-optimized predictions in days, significantly reducing the need for costly wet-lab trials. The service is designed to streamline R&D workflows while ensuring full client confidentiality and IP ownership.
Target Audience
Primary customers are research scientists and biotech companies in drug discovery and development who need to produce proteins efficiently for research, screening, and therapeutic applications.
Features
- AI-driven predictions for protein expression optimization in E. coli, S. cerevisiae, and CHO cells.
- Replaces months of trial-and-error with results delivered in days.
- Reduces wet-lab experiment costs by 90% or more.
- Secure platform guaranteeing full client confidentiality and IP ownership.
- Developed with expertise in protein engineering and AI/ML.